Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Sen. Sanders, Rep. Cummings to introduce bill to lower U.S. drug prices

U.S. Senator Bernie Sanders and Representative Elijah Cummings plan to introduce legislation aimed at lowering the cost of prescription drugs for U.S. consumers.

Read More »

Survey Indicates Healthcare Professionals Have a Dim View of Post-Brexit Britain

A new report indicates that the so-called “Brexit” will have a negative impact on healthcare in the United Kingdom.

Read More »

WHO uncovers big national variations in antibiotics consumption

Antibiotics are used far more in some countries than in others, a survey by the World Health Organization showed, suggesting that urgent action was needed to slash unnecessary consumption of the medicines.

Read More »

UK clinical trials fall as Brexit clouds drug approval process

The number of new clinical trials started in Britain during 2017 was 25 percent lower than the average for 2009-2016, as anxiety about Brexit’s impact on future medicines regulation made companies hesitate about running studies in the country.

Read More »

Novo Nordisk to cut 250 jobs in the United States

Denmark’s Novo Nordisk will cut around 250 jobs in the United States, but the drugmaker will also hire an as-yet undetermined number of staff to new positions.

Read More »

Novo Nordisk lays off 400 staff in R&D unit

Novo Nordisk said the world’s top maker of diabetes drugs will lay off 400 staff in Denmark and China as part of a broader restructuring of the company’s research and development organization.

Read More »

Half of Europe’s clinical trials fail to report results

Almost half of all European-registered clinical trials have breached EU rules by failing to report results, according to a published analysis.

Read More »

Biogen’s muscle drug Spinraza too costly for Britain

Biogen’s muscle disease treatment Spinraza has been deemed too expensive for use on Britain’s state-run health service, even after a price discount offered by the U.S. drugmaker.

Read More »

Sanofi, Novartis latest to stockpile drugs in case of no-deal Brexit

Sanofi and Novartis said on Wednesday they planned to increase stockpiles of medicines Britain in preparation for potential disruption if the UK crashes out of the European Union without a deal.

Read More »

EU drug regulators step up work to prepare for ‘no deal’ Brexit

Drug regulators across Europe are hiring extra staff and increasing their workload as the role of British experts in the EU-wide system of medicines supervision winds down ahead of Brexit.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

December 2018 Focus: Healthcare Agency Roundtable, Mobile Marketing, and more!

Subscribe

Ad Right Bottom